COVID-19 VACCINE ASTRAZENECA GUIDANCE FOR HEALTH CARE PROVIDERS
HTAC recommends COVID-19 Vaccine AstraZeneca under emergency use for reducing COVID-19 risk in persons aged 18 and older

PFIZER-BIONTECH COVID-19 VACCINE for health care providers

HTAC recommends Pfizer-BioNTech COVID-19 Vaccine under emergency use for reducing COVID-19 risk in persons aged 16 and older

HTA Philippines publishes HTAC Evaluation Framework for COVID-19 Vaccines

URGENT HIRING
HTAC recommends pooled RT-PCR testing to monitor COVID transmission in populations with low case numbers

HTAC recommends Rapid Antigen Test kits for symptomatic COVID-19, contact tracing, managing outbreaks and supplementing lack of RT-PCR confirmatory testing

Strengthening COVID-19 response in the Philippines through Health Technology Assessment: A webinar for Evidence-Based Health Care (EBHC) Day 2020.
HTAC releases guidance for ECMO, notes insufficient evidence to recommend use
HTA and the COVID-19 pandemic
DOH Releases New Implementing Guidelines on HTA
    DOH holds first HTA public consultation
DOH holds HTA Workshop and Policy Symposium
Towards UHC: DOH and PhilHealth gear up for HTA
DOH holds high-level forum to accelerate HTA
DOH convenes local experts to create HTAC

EVENTS AND PRESS RELEASES

READ MORE

HTAC RECOMMENDATIONS

READ MORE
FOR STAKEHOLDER CONSULTATION


News briefs

CONTACT US

Business Hours: 

8:00 a.m. to 5:00 p.m. (GMT+8)  |  Monday to Friday

 Email: 

hta@doh.gov.ph

Telephone:

8-875-7734 ext. 260

Address:

4th Floor, Philippine Blood Disease and Transfusion Center, Lung Center Compound, Quezon Avenue, Diliman, Quezon City